BioCryst Pharmaceuticals, Inc. Financial Ratios — BCRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-141.82	- -	- -	- -	-69.75	-223.7	-154.16	-152.26	-248.94	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-59.43	-55.97	-56.64	-48.66	-33.19	-51.97	-49.07	-62.29	-67.61	-71.69	-39.89	-43.42	-42.46	-17.65	52.53
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	104.73
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	103.13
Gross Margin (%)	100	99.5	99.43	99.1	96.07	89.76	93.24	97.72	91.6	90.59	95.38	97.57	98.65	97.28	97.82
EBITDA Margin (%)	-247.93	-119.81	-175.48	-335.05	-81.36	-182.61	-225.15	-452.48	-202.17	-976.92	-112.58	-54.28	-30.79	-0.29	39.14
Operating Margin (%)	-252.44	-122.2	-177.24	-336.35	-81.74	-184.45	-227.95	-456.2	-203.66	-981.12	-113.08	-54.81	-31.29	-0.56	38.98
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	81
Pretax Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-115.68	-90.24	-68.26	-19.29	30.56
Profit Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-117.11	-91.24	-68.36	-19.72	30.16
Net Income to Common Margin (%)	-289.91	-148.64	-173.72	-332.08	-89.15	-209.25	-261.18	-490.25	-222.99	-1,026.35	-117.11	-91.24	-68.36	-19.72	30.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.32
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-141.82	- -	- -	- -	-69.75	-223.7	-154.16	-152.26	-248.94	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	30	30	30	30	30	54	55	62	85	280	593	741	825	809	439
ST Debt	- -	- -	- -	30	28	28	35	34	40	31	2	2	3	3	2
LT Debt	30	30	30	- -	2	25	20	28	45	248	591	739	822	806	437
Total Debt/EBITDA	-0.62	-0.95	-0.99	-0.66	-0.77	-1.12	-0.96	-0.66	-0.86	-1.61	-3.35	-5.04	-8.09	-623.55	1.28
Net Debt/EBITDA	-0.28	-0.29	-0.29	0.54	0.03	-0.6	-0.03	-0.35	0.35	-0.01	-0.46	-2.92	-6.87	-532.93	0.99
Total Debt/EBIT	-0.6	-0.93	-0.98	-0.66	-0.77	-1.11	-0.95	-0.66	-0.85	-1.6	-3.34	-5	-7.96	-318.03	1.29
Net Debt/EBIT	-0.27	-0.28	-0.29	0.54	0.03	-0.59	-0.03	-0.34	0.34	-0.01	-0.46	-2.89	-6.76	-271.81	0.99
EBITDA to Interest Expense	-12.9	-6.75	-6.37	-9.12	-7.55	-7.42	-6.62	-10.18	-8.3	-12	-2.98	-1.48	-0.94	-0.01	4.34
EBITDA-CapEx/Interest Expense	-12.92	-6.78	-6.37	-9.14	-8.54	-8.23	-6.66	-10.22	-8.33	-12.04	-3.02	-1.5	-0.96	-0.02	4.31
EBIT to Interest Expense	-13.14	-6.89	-6.43	-9.16	-7.59	-7.49	-6.7	-10.27	-8.36	-12.05	-3	-1.5	-0.96	-0.03	4.32
Interest Expense	4	5	5	5	5	6	9	9	12	15	59	99	108	99	79
Common Equity/Total Assets	18.01	-0.79	-2.3	55.26	39	1.76	46.99	33.53	21.82	-5.75	-18.19	-53.56	-88.12	-97.05	-23.17
Long-Term Debt/Equity (%)	202.62	- -	- -	- -	4.98	1,614.77	23.28	57.02	116.84	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	66.96	101.54	103.9	- -	3.05	46.08	14.08	25.28	36.37	95.42	121.63	165.4	222.53	242.17	136.76
Long-Term Debt/Total Assets (%)	36.49	52.23	61.39	- -	1.94	28.36	10.94	19.12	25.5	74.19	100.56	134.38	159.1	164.34	85.04
Total Debt/Equity (%)	202.62	-6,607.93	-2,664.3	39.66	63.24	3,404.56	65.33	125.57	221.3	-1,451.05	-554.5	-251.68	-181.14	-169.93	-368.33
Total Debt/Capital (%)	66.96	101.54	103.9	28.4	38.74	97.15	39.51	55.67	68.88	107.4	122	165.93	223.24	243.01	137.27
Total Debt/Total Assets (%)	36.49	52.23	61.39	21.92	24.66	59.79	30.7	42.1	48.3	83.5	100.86	134.81	159.62	164.91	85.36
Net Debt to Equity	91.56	-2,006.39	-784.72	-32.45	-2.29	1,832.45	1.93	65.69	-89.67	-12.07	-75.77	-145.46	-153.8	-145.23	-283.25
Net Debt/Capital (%)	47.8	105.25	114.6	-48.03	-2.23	87.1	1.83	38.35	-392.79	-19.56	-446.98	301.58	270.53	303.04	146.75
EBITDA	-49	-32	-30	-46	-39	-48	-57	-93	-99	-174	-177	-147	-102	-1	342
EBITDA-CapEx	-49	-32	-30	-46	-44	-53	-57	-94	-99	-175	-179	-148	-104	-2	340
Operating Income (Loss)	-50	-32	-31	-46	-39	-49	-57	-94	-99	-175	-178	-148	-104	-3	341

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.59	2.07	2.49	1.27	0.83	1.01	1.53	1.5	1.48	2.84	4.89	4.02	2.59	2	1.4
Current Ratio	2.01	2.44	2.76	1.56	1.02	1.23	1.68	1.65	1.78	3.06	5.46	4.9	3.31	2.63	2.06
Quick Ratio	1.87	2.33	2.63	1.44	0.93	1.17	1.61	1.57	1.72	2.92	5.18	4.5	2.97	2.49	1.95
CFO/Avg Current Liab	-1.19	-1.72	-1.63	-1.06	-0.22	-0.92	-0.64	-1.28	-1.11	-1.36	-1.36	-1.55	-0.74	-0.34	1.95
Common Equity/Total Assets	18.01	-0.79	-2.3	55.26	39	1.76	46.99	33.53	21.82	-5.75	-18.19	-53.56	-88.12	-97.05	-23.17
Long-Term Debt/Equity (%)	202.62	- -	- -	- -	4.98	1,614.77	23.28	57.02	116.84	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	66.96	101.54	103.9	- -	3.05	46.08	14.08	25.28	36.37	95.42	121.63	165.4	222.53	242.17	136.76
Long-Term Debt/Total Assets (%)	36.49	52.23	61.39	- -	1.94	28.36	10.94	19.12	25.5	74.19	100.56	134.38	159.1	164.34	85.04
Total Debt/Equity (%)	202.62	-6,607.93	-2,664.3	39.66	63.24	3,404.56	65.33	125.57	221.3	-1,451.05	-554.5	-251.68	-181.14	-169.93	-368.33
Total Debt/Capital (%)	66.96	101.54	103.9	28.4	38.74	97.15	39.51	55.67	68.88	107.4	122	165.93	223.24	243.01	137.27
Total Debt/Total Assets (%)	36.49	52.23	61.39	21.92	24.66	59.79	30.7	42.1	48.3	83.5	100.86	134.81	159.62	164.91	85.36
CFO/Total Liabilities	-47.85	-64.6	-53.07	-62.95	-17.57	-60.54	-43.54	-94.84	-65.38	-38.17	-20.45	-19.16	-9.78	-5.38	54.85
CFO/CapEx	-586.38	-330.95	-884.33	-363.69	-2.56	-10.13	-125.44	-252.91	-261.18	-262.86	-59.6	-119.8	-43.88	-46.28	140.75
Altman's Z-Score	-6.38	-9.69	-7.78	3.06	-0.41	-6.97	-2.48	-3.13	-5.49	-2.93	-0.46	-1.67	-3.01	-2.54	1.85

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	1.09	5.06	5.19	2.35	6.13	3.51	3.38	3.97	3.69	1.16	8.26	6.77	6.16	6.63	9.41
Days Sales Outstanding	335.01	72.14	70.31	155.64	59.5	103.95	107.86	91.99	98.8	315.49	44.19	53.92	59.22	55.08	38.78
Inventory Turnover	- -	1	- -	0.36	1.65	2.56	6.81	0.57	4.97	0.48	0.64	0.3	0.16	0.67	2.83
Days Inventory Outstanding	- -	363.62	- -	1,021.7	220.91	142.81	53.61	638.94	73.38	766.48	573.58	1,199.06	2,289.54	546.95	129.02
Accounts Payable Turnover	-0.12	-0.04	0.02	0.23	0.46	0.23	0.23	0.3	0.23	0.53	0.69	0.87	0.32	-0.51	1.19
Accounts Payable Turnover Days	-3,074.62	-9,014.94	15,173.57	1,592.17	785.3	1,561.2	1,610.31	1,214.31	1,619.35	684.79	530.1	419.66	1,142.42	-713.1	305.95
Cash Conversion Cycle	- -	9,450.7	-15,103.26	-414.83	-504.89	-1,314.43	-1,448.84	-483.38	-1,447.17	397.18	87.67	833.32	1,206.35	1,315.13	-138.15
Inventory to Cash Days	- -	-291.48	70.31	-866.06	-161.41	-38.85	54.24	-546.96	25.42	-450.99	-529.39	-1,145.15	-2,230.31	-491.87	-90.24
Inventories	- -	- -	- -	1	2	- -	- -	2	- -	7	16	28	29	8	5
Raw Materials	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	9	6	10	10
Work In Process	- -	- -	- -	- -	2	- -	- -	- -	- -	3	10	15	18	16	13
Finished Goods	4	4	4	- -	- -	- -	- -	- -	- -	5	1	5	6	8	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -	-23	-24

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	113	72	449	875	757	467	483	888	532	1,318	2,553	2,157	1,233	1,568	1,662
- Cash & Cash Equivalents	16	21	21	55	29	22	50	27	114	272	504	305	111	105	90
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	30	30	30	30	30	54	55	62	85	280	593	741	825	809	439
Enterprise Value	101	67	441	832	736	466	424	846	480	1,297	2,639	2,474	1,669	2,056	1,826
Total Capital	45	30	29	106	78	55	138	111	123	260	486	447	370	333	320
Total Debt/Capital (%)	66.96	101.54	103.9	28.4	38.74	97.15	39.51	55.67	68.88	107.4	122	165.93	223.24	243.01	137.27
Total Debt / EV	0.3	0.45	0.07	0.04	0.04	0.12	0.13	0.07	0.18	0.22	0.22	0.3	0.49	0.39	0.24
EV/Sales	5.15	2.54	25.45	61.16	15.24	17.69	16.82	40.94	9.83	72.81	16.79	9.14	5.04	4.56	2.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.33
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.35
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	125.98	42.24	4.29
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	108.26	41.29	4.27
Diluted Market Cap	112	70	420	812	752	467	415	833	399	1,246	2,481	2,134	1,151	1,554	1,705
Diluted Enterprise Value	125	79	428	787	754	498	419	868	369	1,254	2,570	2,571	1,866	2,258	2,054
EV per Share	2.21	1.31	7.46	11.57	10.03	6.32	4.3	7.68	3.12	7.33	14.31	13.17	8.11	9.86	8.57
TTM Sales	20	26	17	14	48	26	25	21	49	18	157	271	331	451	875
TTM EBITDA	-49	-32	-30	-46	-39	-48	-57	-93	-99	-174	-177	-147	-102	-1	342
TTM Operating Income	-50	-32	-31	-46	-39	-49	-57	-94	-99	-175	-178	-148	-104	-3	341
TTM Cash Flow to Firm	-28	-33	-22	-34	-8	-47	-33	-83	-78	-121	-82	-62	13	49	425
TTM Free Cash Flow to Firm	-28	-33	-22	-33	-3	-42	-32	-83	-77	-120	-80	-60	15	50	428

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-3.46	-1.88	-15.84	-21.12	-94.11	-9.69	-10.16	-9.03	-4.47	-9.26	-17.75	-13.3	-12.38	-30.54	4.87
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.35
Enterprise Value	101	67	441	832	736	466	424	846	480	1,297	2,639	2,474	1,669	2,056	1,826
Low Price	2.28	1.08	1.12	7.29	7.85	1.63	3.95	4.25	1.38	1.58	7.27	7.61	4.82	4.03	6
EV/Sales	5.15	2.54	25.45	61.16	15.24	17.69	16.82	40.94	9.83	72.81	16.79	9.14	5.04	4.56	2.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.33
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.2
Price/Earnings Average	-2.71	-4.58	-6.75	-16.15	-19.09	-5.58	-7.38	-6.41	-5.31	-3.71	-12.9	-9.72	-6.49	-15.35	6.54
Price/Earnings High	-4.3	-7.53	-14.38	-21.6	-28.52	-13.69	-11.88	-9.9	-10.56	-8.23	-17.98	-15.04	-10.25	-20.65	9
Price/Earnings Low	-1.81	-1.37	-2.05	-10.77	-13.3	-2.18	-5.07	-4.33	-1.46	-1.45	-7.07	-5.73	-4.09	-9.37	4.77
Price/Book Value	7.62	-159.18	-398.84	11.57	15.86	295.97	5.77	18.04	13.9	-68.41	-23.87	-7.32	-2.71	-3.3	-13.95
Price/Book Value Average	10.53	-405.99	-193.07	10.4	17.31	195.29	6.75	14.06	20.16	-37.26	-22.85	-8.24	-3.45	-2.89	-14.71
Price/Book Value High	16.75	-666.99	-411.44	13.91	25.87	478.79	10.87	21.71	40.08	-82.56	-31.84	-12.75	-5.46	-3.89	-20.22
Price/Book Value Low	7.03	-121.07	-58.78	6.94	12.07	76.21	4.64	9.5	5.56	-14.51	-12.53	-4.85	-2.18	-1.77	-10.73
Price/Tangible Book Value	7.62	-159.18	-398.84	11.57	15.86	295.97	5.77	18.04	13.9	-68.41	-23.87	-7.32	-2.71	-3.3	-13.95
Price/Tangible Book Value Average	10.53	-405.99	-193.07	10.4	17.31	195.29	6.75	14.06	20.16	-37.26	-22.85	-8.24	-3.45	-2.89	-14.71
Price/Tangible Book Value High	16.75	-666.99	-411.44	13.91	25.87	478.79	10.87	21.71	40.08	-82.56	-31.84	-12.75	-5.46	-3.89	-20.22
Price/Tangible Book Value Low	7.03	-121.07	-58.78	6.94	12.07	76.21	4.64	9.5	5.56	-14.51	-12.53	-4.85	-2.18	-1.77	-10.73
Price/Sales	5.68	2.67	24.21	59.67	15.59	17.7	16.46	40.32	8.17	69.96	15.78	7.88	3.47	3.45	1.87
Price/Sales Average	7.85	6.81	11.72	53.64	17.01	11.68	19.27	31.43	11.85	38.1	15.11	8.87	4.44	3.03	1.97
Price/Sales High	12.48	11.2	24.98	71.74	25.42	28.64	31.02	48.51	23.55	84.42	21.06	13.72	7.01	4.07	2.71
Price/Sales Low	5.24	2.03	3.57	35.77	11.86	4.56	13.24	21.23	3.27	14.84	8.29	5.22	2.8	1.85	1.44
Price/Cash Flow	-3.46	-1.88	-15.82	-21.06	-57.36	-8.73	-10.08	-9	-4.45	-9.22	-17.45	-13.19	-12.1	-29.88	4.71
Price/Cash Flow Average	-4.78	-4.79	-7.66	-18.93	-62.6	-5.76	-11.8	-7.01	-6.46	-5.02	-16.71	-14.84	-15.45	-26.22	4.97
Price/Cash Flow High	-7.6	-7.87	-16.32	-25.32	-93.54	-14.12	-18.99	-10.82	-12.84	-11.13	-23.28	-22.96	-24.4	-35.28	6.83
Price/Cash Flow Low	-3.19	-1.43	-2.33	-12.63	-43.63	-2.25	-8.11	-4.74	-1.78	-1.96	-9.16	-8.74	-9.75	-16.01	3.63
Price/Free Cash Flow Average	-4.79	-4.81	-7.67	-18.99	-102.71	-6.39	-11.89	-7.04	-6.48	-5.04	-16.99	-14.97	-15.81	-26.8	5.14
Price/Free Cash Flow High	-7.61	-7.9	-16.34	-25.39	-153.48	-15.67	-19.14	-10.87	-12.89	-11.17	-23.68	-23.15	-24.97	-36.06	7.07
Price/Free Cash Flow Low	-3.2	-1.43	-2.33	-12.66	-71.59	-2.49	-8.17	-4.76	-1.79	-1.96	-9.32	-8.81	-9.97	-16.37	3.75
EV/Sales Average	8.63	7.36	13.05	56	17.15	12.89	22.64	35.22	15.19	40.7	16.12	10.58	6.9	4.62	2.4
EV/Sales High	13.31	11.86	27.24	75.5	25.61	29.87	36.32	53.45	30.79	89.69	22.24	15.48	9.66	5.67	3.15
EV/Sales Low	5.99	2.44	4.33	36.74	11.96	5.76	15.61	24.35	3.75	16.1	9.09	6.89	5.15	3.43	1.86
EV/EBITDA Average	-3.48	-6.14	-7.44	-16.71	-21.07	-7.06	-10.05	-7.78	-7.51	-4.17	-14.32	-19.49	-22.42	-1,603.93	6.14
EV/EBITDA High	-5.37	-9.9	-15.52	-22.53	-31.48	-16.36	-16.13	-11.81	-15.23	-9.18	-19.76	-28.52	-31.36	-1,970.62	8.06
EV/EBITDA Low	-2.42	-2.03	-2.47	-10.97	-14.7	-3.16	-6.93	-5.38	-1.85	-1.65	-8.08	-12.7	-16.73	-1,190.79	4.75
EV/EBIT Average	-3.42	-6.02	-7.37	-16.65	-20.98	-6.99	-9.93	-7.72	-7.46	-4.15	-14.25	-19.3	-22.06	-818.05	6.16
EV/EBIT High	-5.27	-9.71	-15.37	-22.45	-31.33	-16.19	-15.93	-11.72	-15.12	-9.14	-19.67	-28.25	-30.86	-1,005.07	8.09
EV/EBIT Low	-2.37	-1.99	-2.44	-10.92	-14.63	-3.12	-6.85	-5.34	-1.84	-1.64	-8.04	-12.58	-16.46	-607.34	4.77
Last Price	2.47	1.42	7.6	12.16	10.32	6.33	4.91	8.07	3.45	7.45	13.85	11.48	5.99	7.52	7.8
High Price	5.43	5.95	7.84	14.62	16.83	10.24	9.25	9.71	9.95	8.99	18.48	19.99	12.08	8.88	11.31
Enterprise Value Average	170	193	226	762	827	340	570	727	742	725	2,533	2,865	2,288	2,080	2,102
Enterprise Value High	262	312	472	1,027	1,236	787	915	1,104	1,504	1,598	3,496	4,193	3,200	2,556	2,759
Enterprise Value Low	118	64	75	500	577	152	393	503	183	287	1,429	1,867	1,707	1,544	1,627

Shares Outstanding	46	51	59	72	73	74	98	110	154	177	184	188	206	209	213
Diluted Weighted Avg Shares	45	49	55	67	73	74	84	103	116	167	179	186	192	207	219
Basic Weighted Avg Shares	45	49	55	67	73	74	84	103	116	167	179	186	192	207	210
Revenue per Share	0.44	0.53	0.31	0.2	0.66	0.36	0.3	0.2	0.42	0.11	0.88	1.46	1.72	2.18	4.17
EBITDA per Share	-1.08	-0.64	-0.55	-0.68	-0.54	-0.65	-0.67	-0.91	-0.85	-1.04	-0.99	-0.79	-0.53	-0.01	1.63
Operating Income per Share	-1.1	-0.65	-0.56	-0.69	-0.54	-0.66	-0.68	-0.91	-0.86	-1.04	-0.99	-0.8	-0.54	-0.01	1.62
Basic EPS, GAAP	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.26
Basic EPS from Cont Ops	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.26
Diluted EPS, GAAP	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.21
Diluted EPS from Cont Ops	-1.26	-0.79	-0.55	-0.68	-0.59	-0.75	-0.78	-0.98	-0.94	-1.09	-1.03	-1.33	-1.18	-0.43	1.21
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.71	-0.76	-0.48	-0.58	-0.18	-0.73	-0.49	-0.9	-0.77	-0.81	-0.79	-0.87	-0.5	-0.25	1.65
Free Cash Flow per Basic Share	-0.72	-0.76	-0.48	-0.58	-0.25	-0.8	-0.49	-0.9	-0.78	-0.81	-0.81	-0.88	-0.51	-0.26	1.64
Cash & Equivalents per Share	0.91	0.7	0.64	1.01	0.7	0.74	1.16	0.95	0.88	1.7	2.75	2.26	1.89	1.54	1.29
Book Value per Share	0.32	-0.01	-0.02	1.05	0.65	0.02	0.85	0.45	0.25	-0.11	-0.58	-1.57	-2.21	-2.28	-0.56
Tangible Book Value per Share	0.32	-0.01	-0.02	1.05	0.65	0.02	0.85	0.45	0.25	-0.11	-0.58	-1.57	-2.21	-2.28	-0.56

BioCryst Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)